Literature DB >> 17539000

Three-quarters of right liver donors experienced postoperative complications.

Nam-Joon Yi1, Kyung-Suk Suh, Jai Young Cho, Hae Won Lee, Eung-Ho Cho, Sung Hoon Yang, Yong Beom Cho, Kuhn Uk Lee.   

Abstract

A donor right hepatectomy (RH) is associated with a higher rate of morbidity than a left hepatectomy. Therefore, the precise morbidity should be known to improve the success of donor RH implementation. However, the rate of complication varies according to the individual definition of morbidity. This study prospectively analyzed the outcomes of 83 consecutive living donor RHs between January 2002 and July 2004 using a standardized classification of the severity of complications. The morbidity was classified using the modified Clavien system: grade I for minor complications; grade II for potentially life-threatening complications requiring pharmacological treatment; grade III for complications requiring invasive intervention; grade IV for complications causing organ dysfunction requiring intensive care unit management; and grade V complications resulting in the death of the patient. The donors were followed-up regularly for at least 12 months. No donor death or relaparotomy was noted. Overall, 65 out of 83 donors (78.3%) experienced postoperative complications: grades I, II, III, IV, and V complications in 64 (77.1%), 11 (13.3%), 1 (1.2%), 0, and 0 patients, respectively. The most common grade I complications were hyperbilirubinemia (n = 31) and pleural effusion (n = 31), and bile leakage in grade II (n = 7). The bilirubin and alanine aminotransferase levels were normal in 92.7% of donors at the 1-year follow-up. In conclusion, although most of these adverse events were minor and self-limited, 78% of right liver donors still experienced morbidity. Therefore, continuous standardized reporting of the donor morbidity as well as meticulous surgery and intensive care are essential for the success of donor RH implementation.

Entities:  

Mesh:

Year:  2007        PMID: 17539000     DOI: 10.1002/lt.21030

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  26 in total

Review 1.  Biliary complications in living liver donors.

Authors:  Yufeng Yuan; Mitsukazu Gotoh
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

Review 2.  Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT.

Authors:  Vikram Raut; Ruslan Alikhanov; Jacques Belghiti; Shinji Uemoto
Journal:  Surg Today       Date:  2013-08-01       Impact factor: 2.549

Review 3.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

4.  What is a surgical complication?

Authors:  Daniel Dindo; Pierre-Alain Clavien
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

5.  Remnant left liver size and recovery of living right liver donors.

Authors:  Yuen Ki Fong; See Ching Chan; Tan To Cheung; Wing Chiu Dai; Kenneth S H Chok; Albert C Y Chan; William W Sharr; Chung Mau Lo
Journal:  Hepatol Int       Date:  2012-11-14       Impact factor: 6.047

Review 6.  Pushing the frontiers of living donor right hepatectomy.

Authors:  Seong Hoon Kim; Seung Duk Lee; Young Kyu Kim; Sang-Jae Park
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

7.  Outcome of right hepatectomy for living liver donors: a single Egyptian center experience.

Authors:  Tarek Salah; Ahmad M Sultan; Omar M Fathy; Mohammed M Elshobary; Nabieh A Elghawalby; Ahmed Sultan; Amr M Yassen; Walid M R Elsarraf; Mohammed Elmorshedi; Mohammed F Elsaadany; Usama A Shiha; M Abdel Wahab
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

8.  2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 9.  Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

Authors:  Kyung-Suk Suh; Hae Won Lee
Journal:  Hepat Oncol       Date:  2015-01-12

10.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.